US 12171759
Methods and uses for treating anhedonia
granted A61KA61K31/472A61P
Quick answer
US patent 12171759 (Methods and uses for treating anhedonia) held by Xenon Pharmaceuticals Inc. expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Dec 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/472, A61P, A61P25/24